Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Canadian Critical Care Trials Group | OTHER |
| Canadian National Transplant Research Program | OTHER |
| Transplant Quebec | UNKNOWN |
| Trillium Gift of Life Network |
Not provided
Not provided
Not provided
Not provided
This is a 1-year national prospective cohort study that observes the medical management of consented deceased organ donors at hospitals across Canada with a high volume of deceased donation.
This prospective cohort study enrols consecutive adult deceased organ donors with a waiver of research consent and collects various data related to deceased donor care in the ICU from the time of consent for donation to the time of organ recovery. Clinical data includes donor characteristics, type of donation (after neurological death or cardiocirculatory death), resuscitation methods, cardiopulmonary monitoring techniques, medications, blood work, mechanical ventilation, diagnostic imaging, complications, and methods of death declaration. Various clinical data on deceased donors are collected prospectively from the time of consent for organ donation up to and including the day of organ recovery.
The Canada-DONATE study is designed to develop a national platform for future clinical trials in deceased donor care. The main objectives include:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Consented deceased organ donors | Includes neurological determination of death (DND) and by circulatory determination of death (DCD). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Observational Data Collection | Other | All aspects of deceased donor care in the ICU. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Adherence to national guidelines for deceased donor care | For each donor, we will measure adherence to multiple recommendations from national guidelines for the management of deceased organ donors. | Duration of deceased donor care in the ICU (1-5 days per donor). |
| Measure | Description | Time Frame |
|---|---|---|
| Organ donation | This refers to the conversion of a consented organ donor to an actual organ donor. | Duration of deceased donor care in the ICU (1-5 days per donor). |
| Organ transplantation | Deceased organ donors can provide up to 8 organ donations each. We will measure the number of transplants that proceed from each consented donor. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
All patients for whom consent for deceased organ donation has been obtained.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Frederick D'Aragon, MD, MSc | Université de Sherbrooke | Principal Investigator |
| Maureen O Meade, MD, MSc | McMaster University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Foothills Medical Centre | Calgary | Alberta | T2N 2T9 | Canada | ||
| Royal Alexandra Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32385825 | Derived | D'Aragon F, Lamontagne F, Cook D, Dhanani S, Keenan S, Chasse M, English S, Burns KEA, Frenette AJ, Ball I, Boyd JG, Masse MH, Breau R, Akhtar A, Kramer A, Rochwerg B, Lauzier F, Kutsogiannis DJ, Ibrahim Q, Hand L, Zhou Q, Meade MO; Canadian Critical Care Trials Group and the Canadian Donation and Transplant Research Program. Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study. Can J Anaesth. 2020 Aug;67(8):992-1004. doi: 10.1007/s12630-020-01692-7. Epub 2020 May 8. | |
| 28963316 |
| Label | URL |
|---|---|
| Canada-DONATE Research Progam Website | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| UNKNOWN |
| BC Transplant | UNKNOWN |
| Southern Alberta Organ Donation Program | UNKNOWN |
| Human Organ Procurement and Exchange | UNKNOWN |
| Canadian Blood Services | OTHER |
| Hamilton Health Sciences Corporation | OTHER |
Not provided
Not provided
Not provided
| Transplantation may occur from 1-5 days from the time of consent. |
| Edmonton |
| Alberta |
| T5H 3V9 |
| Canada |
| University of Alberta Hospital | Edmonton | Alberta | T6G 2B7 | Canada |
| Royal Columbian Hospital | New Westminster | British Columbia | V3L 3W7 | Canada |
| Vancouver General Hospital | Vancouver | British Columbia | V5Z 1M9 | Canada |
| St. Paul's Hospital | Vancouver | British Columbia | V6Z 1Y6 | Canada |
| Royal Jubilee Hospital | Victoria | British Columbia | V8R 1J8 | Canada |
| Victoria General Hospital | Victoria | British Columbia | V8Z 6R5 | Canada |
| Hamilton Health Sciences - Hamilton General Hospital | Hamilton | Ontario | L8L 2X2 | Canada |
| Hamilton Health Science - Juravinski Hospital | Hamilton | Ontario | L8V 1C3 | Canada |
| Kingston General Hospital | Kingston | Ontario | K7L 2V7 | Canada |
| London Health Sciences Centre - University Hospital | London | Ontario | N6A 5A5 | Canada |
| London Health Sciences Centre - Victoria Hospital | London | Ontario | N6A 5W9 | Canada |
| Trillium Health Partners - Trillium Health Centre | Mississauga | Ontario | L5B 1B8 | Canada |
| The Ottawa Hospital - Civic Campus | Ottawa | Ontario | K1H 8G7 | Canada |
| The Ottawa Hospital - General Hospital | Ottawa | Ontario | K1H 8L6 | Canada |
| Sunnybrook Health Sciences Centre | Toronto | Ontario | M4N 3M5 | Canada |
| St Michael's Hospital | Toronto | Ontario | M5B 1W8 | Canada |
| University Health Network - Toronto General Hospital | Toronto | Ontario | M5G 2C4 | Canada |
| University Health Network - Toronto Western Hospital | Toronto | Ontario | M5T 2S8 | Canada |
| Hôpital Maisonneuve-Rosemont | Montreal | Quebec | H1T 2M4 | Canada |
| Centre hospitalier de l'Université de Montréal - Hôpital Notre-Dame | Montreal | Quebec | H2L 4M1 | Canada |
| Centre hospitalier de l'Université de Montréal - Hôtel-Dieu de Montréal | Montreal | Quebec | H2W 1T8 | Canada |
| Centre hospitalier de l'Université de Montréal - Hôpital Saint-Luc | Montreal | Quebec | H2X 3J4 | Canada |
| Centre Universitaire de Santé McGill/McGill University Health Centre - Hôpital Général de Montreal | Montreal | Quebec | H3G 1A4 | Canada |
| Centre Universitaire de Santé McGill/McGill University Health Centre - Hôpital Royal Victoria | Montreal | Quebec | H4A 3J1 | Canada |
| Hôpital du Sacré-Cœur de Montréal | Montreal | Quebec | H4J 1C5 | Canada |
| Centre Hospitalier Universitaire de Sherbrooke | Sherbrooke | Quebec | J1H 5N4 | Canada |
| Centre Hospitalier Universitaire de Québec - Université Laval | Québec | G1V 4G2 | Canada |
| Derived |
| D'Aragon F, Dhanani S, Lamontagne F, Cook DJ, Burns K, Akhtar A, Chasse M, Frenette AJ, Keenan S, Lize JF, Kutsogiannis DJ, Kramer A, Hand LE, Arseneau E, Masse MH, Ribic C, Ball I, Baker A, Boyd G, Rochwerg B, Healey A, Hanna S, Guyatt GH, Meade MO; Canadian Critical Care Trials Group and the Canadian National Transplant Research Program. Canada-DONATE study protocol: a prospective national observational study of the medical management of deceased organ donors. BMJ Open. 2017 Sep 28;7(9):e018858. doi: 10.1136/bmjopen-2017-018858. |
| ID | Term |
|---|---|
| D016638 | Critical Illness |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided